Technical breakthrough · 11. March 2019
SYnAbs generates custom monoclonal antibodies against synthetic peptide to early diagnose schizophrenia mental disorder
Congress · 05. February 2019
MAb experts (SYnAbs, RDBiotech, Diaclone and QVQ companies) presents its one-stop-shop solution during Buzz4Bio event in France
Technical breakthrough · 28. January 2019
Production of guinea pig monoclonal antibody directed against a steroid hormone and its binding study thanks to Surface Plasmon Resonance imaging technology
Technical breakthrough · 15. January 2019
Hemoglobinopathia are diseases associated with a genetic abnormality of hemoglobin, blood protein used to transport oxygen. Hemoglobin is found basically inside red blood cells (erythrocytes), which gives them their red color. Human hemoglobin consists of four identical chains : - two α chains - two β chains Each of these channels is associated with a prosthetic grouping called heme. The name of hemoglobin comes from two words: heme and globin, symbolized by "Hb". The alpha and beta genes of...
Congress · 14. November 2018
SYnAbs is waiting for you at Medica on booth H3K74! See you there to discuss custom mAb generation projects against tricky antigens: polysaccharide, steroid, PTM on DNA, lipid, small molecule, peptide...
Congress · 31. October 2018
SYnAbs is looking for distributors in Australia for its unique catalog of secondary monoclonal antibodies, isotype controls and anti-isotypes references
Distribution agreement · 01. October 2018
SYnAbs is entering into a strategic deal with DBA Italia for distribution of unique mAbs in Italy!